Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
    • Transcripts
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Log in to your Inderes Free account to see all free content on this page.
Create account

Bittium

31.95 EUR

-0.16 %

8,129 following

BITTI

NASDAQ Helsinki

Telecommunications

Technology

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-0.16 %
+6.68 %
+60.88 %
+125.00 %
+276.77 %
+379.73 %
+657.11 %
+439.70 %
+108.75 %

Bittium specializes in developing secure communication and connectivity solutions using technology and knowledge of radio technology. The products are used for mobile devices, computers, and other technological products in healthcare, defense, and other industries. Examples of work areas include cardiology, neurology, and rehabilitation. The company is headquartered in Oulu.

Read more
Market cap
1.14B EUR
Turnover
4.02M EUR
P/E (adj.) (25e)
EV/EBIT (adj.) (25e)
EV/S (25e)
Dividend yield-% (25e)
Coverage
Recommendation
Reduce
Target price
Updated
27.10.2025
Disclaimer
Juha Kinnunen
Juha Kinnunen

Analyst

Latest research

Latest analysis report

Released: 26.03.2025

Latest extensive report

Released: 28.05.2024

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19.2.
2026

Annual report '25

22.4.
2026

General meeting '26

29.4.
2026

Business review Q1'26

Risk
Business risk
Valuation risk
Low
High
All
Research
Webcasts
Press releases
ShowingAll content types
European Defense Sector Outlook: Long-cycle rearmament drives fundamentals, but stretched valuations force selectivity
Analyst Comment12/30/2025, 8:39 AM by
Renato Rios, Henri Vanhanen

European Defense Sector Outlook: Long-cycle rearmament drives fundamentals, but stretched valuations force selectivity

Peace talks change headlines, not procurement, rearmament keeps rolling ahead.

SaabW5 SolutionsArgo Defence GroupScandinavian Astor GroupScandinavian Astor GroupMilDef GroupINVISIOBittium
European Defense Sector Outlook: Long-cycle rearmament drives fundamentals, but stretched valuations force selectivity
Article12/30/2025, 6:15 AM by
Renato Rios, Henri Vanhanen

European Defense Sector Outlook: Long-cycle rearmament drives fundamentals, but stretched valuations force selectivity

Peace talks change headlines, not procurement, rearmament keeps rolling ahead.

SaabBittiumW5 SolutionsScandinavian Astor GroupScandinavian Astor GroupMilDef GroupINVISIOArgo Defence Group
Regulatory press release12/29/2025, 1:30 PM

Bittium Oyj: Inside Information: Bittium Wireless Ltd, a Subsidiary of Bittium Corporation licenses its Tough SDR Technology to Spanish Indra Group

Bittium

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
Create account
Regulatory press release12/29/2025, 1:30 PM

Bittium Oyj: Inside Information, Profit Warning: Bittium Corporation Raises its Financial Outlook for 2025

Bittium
Regulatory press release12/19/2025, 12:45 PM

Bittium Oyj: Bittium Corporation's Financial Calendar for the Year 2026

Bittium
Regulatory press release12/17/2025, 3:10 PM

Bittium Oyj: Inside Information: Significant Order for Bittium Wireless Ltd, a Subsidiary of Bittium Corporation, for Expanding the Austrian Armed Forces' Tactical Communications Network

Bittium
Regulatory press release12/17/2025, 9:00 AM

Bittium Oyj: Inside Information: Bittium Wireless Ltd, a Subsidiary of Bittium Corporation, Continues Supplying the Finnish Defence Forces with Next-Generation Bittium Tough SDR™ Radios

Bittium
Life Science Companies as Investments | Life Science Night Dec. 9, 202514:40
Video12/16/2025, 7:30 AM

Life Science Companies as Investments | Life Science Night Dec. 9, 2025

Antti Siltanen, Life Science Analyst, PhD, talks about life science companies as investments.

Aiforia TechnologiesBioretecBiohitFaron PharmaceuticalsModulightNexstimOrionBittiumDetection TechnologyOptomedRevenio GroupNightingale HealthHerantis PharmaNanoform Finland
Regulatory press release11/5/2025, 11:30 AM

Bittium Oyj: Inside Information: Bittium Corporation's Subsidiary Bittium Wireless Ltd has signed a Framework Agreement in the Field of Command-and-Control Systems with the Finnish and Swedish Defence Forces

Bittium
Regulatory press release10/24/2025, 5:00 AM

Bittium Oyj: Bittium Corporation's Business Review January-September 2025

Bittium
Bittium's Capital Markets Day 2025
Webcast9/23/2025, 9:30 AM

Bittium's Capital Markets Day 2025

During the day, Petri Toljamo, the CEO of Bittium and the Heads of Company’s Business Segments will provide information about development of the markets relevant to Bittium, long-term growth opportunities and growth strategies.

Bittium
Regulatory press release9/23/2025, 5:30 AM

Bittium Oyj: Inside Information: Bittium Corporation Updates its Long-Term Financial Targets and Refines Its Strategy for 2026-2028

Bittium
Regulation of medical devices and diagnostics in Europe
Analyst Comment9/19/2025, 5:18 AM by
Antti Siltanen

Regulation of medical devices and diagnostics in Europe

The EU is the world's second largest market for medical devices after the United States. In this article, we will go through the basics of EU regulation from an investor's perspective.

BioretecAiforia TechnologiesNexstimBiohitOptomedRevenio GroupModulightDetection TechnologyNightingale HealthBittium
Regulatory press release9/8/2025, 9:45 AM

Bittium Oyj: Inside Information: Bittium Corporation Launches New Ultra Secure Bittium Tough Mobile 3 and Establishes a Strategic Collaboration with HMD Secure Oy

Bittium
Classification of medical devices and regulatory processes in the United States
Analyst Comment9/8/2025, 9:56 AM by
Antti Siltanen

Classification of medical devices and regulatory processes in the United States

We continue our series of articles focusing on Life Science investing, the first four parts of which focused on drug development. Subsequent articles will cover medical devices.

BioretecNexstimOptomedRevenio GroupModulightBittiumDetection Technology
Bittium, Webcast, Q2'25
Webcast8/8/2025, 6:00 AM

Bittium, Webcast, Q2'25

Bittium
Regulatory press release8/8/2025, 5:00 AM

Bittium Oyj: Bittium Corporation's Half-Year Financial Report January-June 2025

Bittium
Regulatory press release7/18/2025, 9:45 AM

Bittium Oyj: Inside Information: Bittium Corporation's Subsidiary Bittium Wireless Ltd. and Indra Group to Sign a Letter of Intent for Strategic Cooperation on Tactical Radio Communications Solution

Bittium
Regulatory press release7/11/2025, 10:00 AM

Bittium Oyj: Bittium Corporation's Comment on Market Information Regarding the Possible Procurement of Tactical Radios by the Spanish Armed Forces

Bittium
Regulatory press release6/10/2025, 1:15 PM

Bittium Oyj: Inside Information: Bittium Wireless Ltd, a Subsidiary of Bittium Corporation, Received a Purchase Order from the Finnish Defence Forces for Bittium TAC WIN™ and Bittium Tough Comnode™ Products

Bittium
Forum discussions
Hi @Tallitonttu, Kiitos kysymyksistä. The €50 million order is a contract-based order for a license. As a whole, such a license deal includes license revenue, technology and production transfer projects, and eventually royalty income. We have agreed with the customer not to disclose...
12/31/2025, 2:12 PM
by Karoliina_Malmi
58
I couldn’t really find a better thread for this, but the admins can move it elsewhere if needed. The investment year has been very good for me in the big picture (ytd 22%), but the biggest “blunder” this year has been with Bittium. I don’t know if there are any kindred spirits here...
12/31/2025, 9:36 AM
by Jageksi
41
Agreed, surprisingly little discussion about the company and its possibilities. There’s much more talk on the neighboring forum, but it’s not particularly high quality… Expectations are certainly baked into the stock, but we haven’t seen Bittium logos tattooed in backs or €30 “hat...
1/9/2026, 10:08 AM
by Osinkohiiri
19
Thank you for the prompt and informative response. And congratulations on closing the Spanish deal. Happy New Year to the entire Bittium team.
12/31/2025, 2:31 PM
by Tonttu
14
I own Bittium I have previously owned Bittium I am considering becoming a Bittium shareholder 0 äänestäjää It’s surprisingly quiet on this forum regarding Helsinki’s top-performing stock from last year. The company currently has such strong prospects that reclaiming that title this...
1/9/2026, 8:17 AM
by ghoul
12
Highest target price. Finn Kemper Cantor Fitzgerald Europe €33 Buy. TradingView BITTI Forecast — Price Target — Prediction for 2027 — TradingView See Bittium Corporation stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better...
1/8/2026, 5:17 AM
by Berswago
11
Thanks for this! Jussi is a positive, down-to-earth, and clear-speaking guy; I recommend giving his channel a listen. As a retail shareholder of Bittium, I was already looking for a change from the “sugar-high” hype that surrounds Bitti. I’ve personally experienced something similar...
12/31/2025, 8:09 AM
by Optis
10
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.